Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PTCT stock price vs OII: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OII's multiple
Needs OII P/E.
Implied fair value · at PTCT's multiple
Needs PTCT P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PTCT FY 2025 (ended Dec 31, 2025) · OII FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 95% equity / 5% debt · EV / Revenue 2.38x · EV / EBITDA 5.50x
Capital structure 91% equity / 9% debt · EV / Revenue 1.76x · EV / EBITDA 11.55x
OII carries the larger enterprise value at $4.91B against $4.13B; OII trades on the lower EV / Revenue multiple (1.76x vs 2.38x); PTCT on the lower EV / EBITDA (5.50x vs 11.55x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
PTC Therapeutics, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
OCEANEERING INTERNATIONAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-1.40x
0.46x
Net debt / EBITDA
Leverage against operating earnings
-2.21x
-0.49x
Cash and equivalents
Liquid reserves on the balance sheet
$1.95B
$695.87M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
VERTEX PHARMACEUTICALS INC / MA
PTCT vs VRTX
Sarepta Therapeutics, Inc.
PTCT vs SRPT
BIOMARIN PHARMACEUTICAL INC
PTCT vs BMRN
ALNYLAM PHARMACEUTICALS, INC.
PTCT vs ALNY
HELIX ENERGY SOLUTIONS GROUP INC
PTCT vs HLX
Baker Hughes Co
PTCT vs BKR
NOV Inc.
PTCT vs NOV
Helmerich & Payne, Inc.
PTCT vs HP
NABORS INDUSTRIES LTD
PTCT vs NBR
Transocean Ltd.
PTCT vs RIG
$286.63M
$487.42M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
